BioCentury | Oct 10, 2017
Distillery Therapeutics

Neurology

...Chemical Co. Ltd. , Eisai Co. Ltd. and Taisho Pharmaceutical Holdings Co. Ltd. market Careram iguratimod...
BioCentury | Dec 7, 2015
Clinical News

Careram regulatory update

...Eisai and Toyama said Japan lifted the condition for approval of Careram/Kolbet iguratimod to treat rheumatoid...
...and Toyama, independently market the product in the country under the brand names Careram and Kolbet...
...Japan Toyama Chemical Co. Ltd. , Tokyo, Japan Product: Careram ( Kolbet ) iguratimod ( T-614...
BioCentury | Mar 12, 2012
Company News

Simcere sales and marketing update

...Simcere disclosed in its 4Q11 earnings that during 1Q12 it launched Iremod iguratimod to treat rheumatoid...
BioCentury | Jan 9, 2012
Finance

PDUFAs produce yawns

...vedotin Hodgkin's lymphoma and anaplastic large cell lymphoma (ALCL) U.S. Simcere Pharmaceutical Group (NYSE:SCR) Iremod iguratimod...
BioCentury | Oct 3, 2011
Finance

Few Cinderellas this time

...icatibant for acute attacks of hereditary angioedema (HAE) Simcere Pharmaceutical Group (NYSE:SCR) China approves Iremod iguratimod...
BioCentury | Sep 5, 2011
Clinical News

Iguratimod regulatory update

...Eisai submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) for iguratimod...
...Ltd. (Tokyo:4523; Osaka:4523), Tokyo, Japan Toyama Chemical Co. Ltd. (Tokyo:4518), Tokyo, Japan Product: Iguratimod ( T-614...
BioCentury | Sep 1, 2011
Company News

Toyama, Eisai seek iguratimod approval in Japan

...partner Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) submitted a regulatory application in Japan for iguratimod ( T-614...
BioCentury | Aug 29, 2011
Finance

Highlights of weekly biotech stock moves

...$0.08 to $8.60 last week after China's State Food and Drug Administration (SFDA) approved Iremod iguratimod...
BioCentury | Aug 29, 2011
Clinical News

Iremod iguratimod regulatory update

...Simcere said China's State Food and Drug Administration approved Iremod iguratimod to treat rheumatoid arthritis (RA...
...Simcere said the compound is a DMARD. Simcere Pharmaceutical Group (NYSE:SCR), Nanjing, China Product: Iremod iguratimod...
BioCentury | Aug 25, 2011
Company News

China approves Simcere's iguratimod for RA

...Simcere Pharmaceutical Group (NYSE:SCR) said China's State Food and Drug Administration approved Iremod iguratimod to treat...
Items per page:
1 - 10 of 11